Showing results (21-30 of 430) with videos related to
Sort By:
Pageof 43
Cancer Treatment Reports|May 1, 1986
Treatment of advanced resistant Hodgkin's disease with lomustine, etoposide, and prednimustineF Cervantes, J C Reverter, E Montserrat, et al.Human Genetics|December 15, 1976
Hereditary hemolytic anemia with erythrocyte pyrimidine 5'-nucleotidase deficiency in Spain. Clinical, biological and familial studiesJ L Vives-Corrons, E Montserrat-Costa, C RozmanBritish Journal of Haematology|March 1, 1986
Lymphocyte doubling time in chronic lymphocytic leukaemia: analysis of its prognostic significanceE Montserrat, J Sanchez-Bisono, N Viñolas, et al.Nouvelle Revue Francaise D'Hematologie|January 1, 1988
Natural history of chronic lymphocytic leukemia: on the progression and progression and prognosis of early clinical stagesE Montserrat, N Viñolas, J C Reverter, et al.Sangre|October 1, 1990
[Effect of the administration of rhGM-CSF in a patient with marrow aplasia resistant to immunosuppressive treatment]P Marín, M Rovira, C Sanz, et al.Leukemia & Lymphoma|July 28, 2016
Efficacy of ABVD Therapy in Resistant Hodgkin's DiseaseE Montserrat, J M Martí, J C Reverter, et al.Medicina Clinica|January 21, 1989
[Analysis of response to treatment. Considerations on changing prognostic variables (time-dependent)]C Rozman, E Montserrat, M Rozman, et al.Hematological Oncology|July 1, 1987
Non-Hodgkin's lymphoma of unfavourable histology: a multivariate analysis of factors predicting the response to CHOPA Pereira, F Cervantes, E Montserrat, et al.Medicina Clinica|October 23, 1993
[Alpha interferon treatment of idiopathic myelofibrosis]F Cervantes, I Alcorta, L Escoda, et al.Leukemia & Lymphoma|July 29, 2016
Interferon alpha-2b for Essential Thrombocythaemia: Results in 13 Previously Untreated PatientsF Cervantes, C Salgado, E Feliu, et al.Pageof 43